Danaher Corporation (DHR)

Investing Cash Flow

-$11.08B

TTM · Period ending: · USD

DHR logo

DHR Investing Cash Flow

Latest reported-$11.08B
DHR TTM Cash from Investing (-$33.00M → -$11.08B)
High-resolution chart · PNG

DHR investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Danaher Corporation Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-11,080,000,000
-11,092,000,000
-1,203,000,000
-1,196,000,000
-1,506,000,000
-1,800,000,000
-1,902,000,000
-1,981,000,000
-7,304,000,000
-7,027,000,000
-7,098,000,000
-7,081,000,000
-1,880,000,000
-2,066,000,000
-2,035,000,000
-2,234,000,000
-2,297,000,000
-11,830,000,000
-12,497,000,000
-12,987,000,000
-12,689,000,000
-2,970,000,000
-1,364,000,000
-21,239,000,000
-20,924,000,000
-20,839,600,000
-21,607,500,000
-1,238,000,000
-1,269,000,000
-1,311,100,000
-3,324,800,000
-2,949,000,000
-2,967,500,000
-2,835,800,000
-802,400,000
-843,400,000
-5,451,400,000
-5,450,000,000
-5,415,000,000
-5,243,000,000
-579,900,000
-14,179,300,000
-14,252,000,000
-14,951,000,000
-17,136,700,000
-3,532,800,000
-3,850,300,000
-3,444,300,000
-978,700,000
-1,512,600,000
-1,391,900,000
-552,500,000
-1,514,100,000
-954,600,000
-1,499,600,000
-1,887,574,000
-1,188,982,000
-1,186,870,000
-5,115,573,000
-5,847,254,000
-6,225,265,000
-6,281,000,000
-1,552,520,000
-2,288,879,000
-2,166,137,000
-2,160,265,000
-2,174,203,000
-942,941,000
-701,610,000
-703,898,000
-584,651,000
-567,399,000
-3,154,747,000
-3,150,553,000
-3,170,337,000
-3,445,759,000
-1,120,118,000
-1,032,274,000
-2,858,439,000
-2,769,370,000
-2,353,776,000
-2,812,288,000
-971,108,000
-965,406,000
-1,072,174,000
-579,633,000
-1,039,934,000
-1,633,631,000
-1,572,554,000
-1,601,500,000
-1,074,187,000
-368,052,000
-399,925,000
-443,127,000
-439,789,000
-1,144,531,000
-1,075,246,000
-1,098,365,000
-1,216,244,000
-487,573,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.